Health
Asia Derma returns to Singapore for second edition
SINGAPORE, Oct. 1, 2019 /PRNewswire/ -- After a successful first run in 2018, Asia Derma, the Asia Pacific Dermatology and Aesthetic Conference & Exhibition returns toSingapore for a second edition. The leading industry event for skin professionals in the region will take place at the Suntec Sing...
AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations
Jeffrey D. Mowery Named Site Head/General Manager BOTHELL, Washington, Oct. 1, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the appointment ofJeffery D. Mowery as Site Head/General Manager of theCopenhagen,...
Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval
SHANGHAI, Sept. 30, 2019 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma) (Hong Kong Stock Exchange: 2607) (Shanghai Stock Exchange: 601607) has launched a new stock incentive plan (the Plan) aligned with international standards aimed at retaining and attracting talent...
Yuyu Pharma Unveils New Corporate Logo
SEOUL, South Korea, Sept. 30, 2019 /PRNewswire/ -- Yuyu's corporate logo was
first created in 1941 to honor the company's proud history and highlight Yuyu's
image as a company on the cutting-edge of the industry.
Amaris B. Clinic, a body management and sculpting clinic, is expanding its services into fitness and injury rehabilitation using vacuum compression therapy in a vacuum pod
SINGAPORE, Sept. 30, 2019 /PRNewswire/ -- Amaris B. Clinic, a provider of Medical Aesthetic services inSingapore, has recently announced its service expansion into the domain of fitness - streamlining its focus toAesthetics, Sculpting and Fitness. An increased awareness among people in regards t...
CKHH Aims to Deconsolidate Chi-Med and to Hold as a Strategic Investment for the Long Term
NEW YORK and LONDON, Sept. 30, 2019 /PRNewswire/ -- CK Hutchison Holdings Limited ("CKHH") announces its intention to sell approximately 1.3% of the total outstanding share capital in Hutchison China MediTech Limited ("Chi-Med") through an underwritten public offering, which would reduce its stak...
ESMO 2019: CStone presents pooled safety data from the Phase 1b trial of CS1001, demonstrating promising overall safety and tolerability
SUZHOU, China, Sept. 30, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) released pooled safety data from the Phase Ib (GEMSTONE-101) study of the Company's anti-PD-L1 antibody CS1001 in a poster presentation at the European Society of Medical Oncology 2019 Con...
Ascletis Announces Departure of Chief Financial Officer
HANGZHOU and SHAOXING, China, Sept. 30, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces that Dr.Lindi Tan, Chi...
Ascletis Announces Departure of Chief Financial Officer
HANGZHOU and SHAOXING, China, Sept. 30, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces that Dr.Lindi Tan, Chi...
First Digital Health Osteoarthritis Wearable Glove System Starts Pre-launch Pilot Trial Series & Medical Tests
MADRID, Sept. 30, 2019 /PRNewswire/ -- QUANTIC NANOTECH
Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis
* Idiopathic pulmonary fibrosis (IPF) is a severe and fatal disease that causes lung damage and scarring * Blocking a protein called interleukin-11 (IL11), which is abnormally high in the lungs of patients with IPF, can reverse lung fibrosis and scarring in preclinical studies * Enleofen Bi...
Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4 Antagonist) for Locally Advanced Rectal Cancer at ESMO 2019
NORTH BRUNSWICK, New Jersey, Sept. 30, 2019 /PRNewswire/ -- Adlai Nortye Ltd. ("Adlai Nortye" or "the Company"), a global clinical-stage biopharmaceutical company dedicated to discovery, development and commercialization of new and effective drugs with a focus on Oncology, announced today at the ...
The 10th China (Taizhou) International Medical Expo successfully ended
NANJING, China, Sept. 30, 2019 /PRNewswire/ -- From September 18 to 20, the 10th
China (Taizhou) International Medical Expo was held in China Medical City
(CMS), according toChina (Taizhou) Medical Expo News Center.
New Major Order From China
STOCKHOLM, Sept. 30, 2019 /PRNewswire/ -- Bactiguard has received a new order from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate revenues in the third quarter of approximatelySEK 4,8 million. "The order we have just received from Well Lead is the first ...
Osteopore debuts on ASX, taking its unique 3D bone implant printing global
PERTH, Australia, Sept. 30, 2019 /PRNewswire/ -- Osteopore International, a Singaporean bone regeneration technology provider has debuted on the Australian Securities Exchange with an AUS$5.25million IPO. With a strong demand, Osteopore shares opened at63 cents and rose to as high as 80 cents on ...
Data From Ascensia Diabetes Care Shows High Accuracy of the CONTOUR®PLUS and CONTOUR®PLUS ONE BGMS in Low Blood Glucose Range and Potential Benefits From Using the CONTOUR®PLUS ONE BGMS With the Health2Sync App
HONG KONG, Sept. 30, 2019 /PRNewswire/ -- At the 21st Diabetes and Cardiovascular Risk Factors – East Meets West Symposium, Ascensia Diabetes Care has presented data from two studies, one analyzing the accuracy of blood glucose monitoring systems (BGMSs) in the low blood glucose range (LBGR) ...
Bridge Biotherapeutics Presents Positive Results from Phase 1 Clinical Study of BBT-877 for Idiopathic Pulmonary Fibrosis (IPF) Treatments at the ERS International Congress 2019
* The study results presented at the ERS 2019 as a late breaking abstract demonstrated positive safety and tolerance in healthy volunteers * Data demonstrated LPA inhibition of BBT-877 up to 90% in multiple-ascending dose cohorts SEONGNAM, South Korea and MADRID, Sept. 29, 2019 /PRNewswire/ --...
Kinoxis Therapeutics Awarded NIH HEAL Initiative Grant to Advance KNX100 for the Treatment of Opioid Withdrawal
MELBOURNE, Australia and SYDNEY, Sept. 29, 2019 /PRNewswire/ -- Kinoxis Therapeutics Pty Ltd, a pre-clinical stage biotechnology company developing novel therapies for substance use disorders and other central nervous system disorders, has been awarded a major grant from the US National Institut...
From broadcast gymnastics to national fitness
BEIJING, Sept. 29, 2019 /PRNewswire/ -- A news report by China.org.cn on China's progress in medical care and people's awareness of health:   "Develop sports, enhance people's physique" used to be a slogan on everybody's lips. In order to enhance people's health, China issued t...
Phase 3 PRIMA trial of Zejula® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardless of biomarker status, when given as monotherapy in women with first-line platinum responsive advanced ovarian cancer
* The PRIMA study, presented in a Presidential Symposium at the 2019 European Society for Medical Oncology congress and simultaneously published inThe New England Journal of Medicine,demonstrates that niraparib treatment resulted in a 38% reduction in the risk of disease progression or death in...
Week's Top Stories
Most Reposted
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
[Picked up by 350 media titles]
2024-09-18 11:30FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
[Picked up by 315 media titles]
2024-09-16 11:50Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
[Picked up by 284 media titles]
2024-09-14 17:37Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
[Picked up by 283 media titles]
2024-09-19 14:00Watsons-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively
[Picked up by 274 media titles]
2024-09-19 08:00